RegulatoryMay 20, 2026, 04:07 PM
AFJK Receives Nasdaq Non-Compliance Notice for Delayed 10-Q
AI Summary
Aimei Health Technology Co., Ltd. (AFJK) announced that it received a notice from Nasdaq on May 19, 2026, indicating non-compliance with Listing Rule 5250(c)(1). This non-compliance stems from the company's delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026, which was due on May 15, 2026. While there is no immediate impact on the trading of its securities, AFJK has 60 calendar days to either file the report or submit a plan to regain compliance, with potential delisting if compliance is not restored. The company stated it is working diligently to file the report and expects to regain compliance.
Key Highlights
- Aimei Health Technology Co., Ltd. (AFJK) received a Nasdaq non-compliance notice on May 19, 2026.
- The notice is due to the delayed filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2026.
- The Quarterly Report was due on May 15, 2026.
- The company is not in compliance with Nasdaq Listing Rule 5250(c)(1).
- The notice has no immediate effect on the listing or trading of AFJK's securities.
- AFJK has 60 calendar days to file the report or submit a plan to regain compliance.
- Failure to regain compliance could lead to delisting from Nasdaq.
- The company is working diligently to complete and file the report and expects to regain compliance.
Price Impact
More from AFJK